Position in PTCT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$752,564
New position
Shares Held
9,226
first reported quarter
Ownership
0.011%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#193
of 380 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empirical Finance, LLC holds $8,529,315 across 6 Biotechnology names. PTCT ranks #4 (8.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,986 | $4,463,615 | |
| 2 | INCY |
Incyte Corp
|
12,461 | $1,412,578 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,482 | $924,086 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
This page
|
9,226 | $752,564 | |
| 5 | MRNA |
Moderna, Inc.
|
9,426 | $660,102 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,478 | $316,370 |
All Filings in PTCT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $752,564 | 9,226 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||